Silver exerts its antimicrobial
effects by interfering with the respiratory
chain at the cytochromes (3). Silver ions also
interfere with components of the microbial
electron transport system, bind DNA and inhibit
DNA replication.
Silver is effective against a
broad range of aerobic, anaerobic, Gram-negative
and Gram-positive bacteria, yeast, filamentous
fungi and viruses.
In order for silver to be
biologically active, it must be in a soluble
form such as Ag+ or Ag0 clusters.
Ag+ is the only form present in silver nitrate,
silver sulfadiazine and other ionic silver
compounds. Ag0 is the metallic or
uncharged form of silver found as one of the
silver species in nanocrystalline, silver
structures. In solution, the Ag° exists in a
sub-crystalline form, less than 8 atoms in
size. Silver nitrate and silver sulfadiazine
release silver at concentrations up to 3,200 ppm
(silver release from silver sulfadiazine is much
slower than that from silver nitrate) but most
of this is rapidly inactivated through the
formation of chemical complexes.
Early silver
formulations compensated for the rapid loss of
silver ions by frequent replacement. Although
this was effective, it created problems for
healthcare professionals and patients, and
resulted in large excesses of silver being
delivered to the wound. In burns units, silver
sulfadiazine is commonly applied twice a day and
silver nitrate up to 12 times a day. Repeated
applications increase discomfort and wound
trauma.
The nature of the solute also
affects the biological activity of silver. In
complex organic biological fluids, continuous
concentrations of silver >50 ppm and as high as
60.5 ppm are needed to kill microbes.
Therefore in wound management,
quantities of silver ion should be sufficient to
provide sustained bactericidal action. Acticoat
with nanocrystalline silver also provides the Ag0
form of silver, which is far less rapidly
deactivated by chloride or organic matter than
the ionic form.